Worth Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Worth Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15	Closed	-$1.12K	–	170
2023 Q2	$1.12K	Buy	15 +7	+88%	+$414	﹤0.01%	412
2023 Q1	$399	Hold	8	–	–	﹤0.01%	459
2022 Q4	$507	Hold	8	–	–	﹤0.01%	445
2022 Q3	$1K	Buy	+8	New	+$953	﹤0.01%	423

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Worth Asset Management's DNA Position: Q3 2023 in Review

Worth Asset Management sold out of Ginkgo Bioworks (DNA) in Q3 2023, closing a stake of 15 shares — an estimated $1.12K sold.

Worth Asset Management first reported a position in DNA in Q3 2022 and held it in 4 quarters. The position peaked at $1.12K in Q2 2023. 348 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

Worth Asset Management reported no remaining Ginkgo Bioworks position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 15 Ginkgo Bioworks shares in Q3 2023, an estimated $1.12K.
Worth Asset Management first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 4 quarters.
Worth Asset Management's Ginkgo Bioworks position peaked at $1.12K in Q2 2023.
348 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.